Anti-HECTD2 antibody [EPR11554]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal HECTD2 antibody. Suitable for WB and reacts with Human samples. Cited in 3 publications.
View Alternative Names
Probable E3 ubiquitin-protein ligase HECTD2, HECT domain-containing protein 2, HECT-type E3 ubiquitin transferase HECTD2, HECTD2
- WB
Supplier Data
Western blot - Anti-HECTD2 antibody [EPR11554] (AB173572)
All lanes:
Western blot - Anti-HECTD2 antibody [EPR11554] (ab173572) at 1/1000 dilution
Lane 1:
MCF-7 cell lysates at 10 µg
Lane 2:
NIH:OVCAR-3 cell lysates at 10 µg
Lane 3:
HeLa cell lysates at 10 µg
Predicted band size: 88 kDa
false
Related conjugates and formulations (1)
-
Anti-HECTD2 antibody [EPR11554] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HECTD2 functions in protein homeostasis and regulates cellular stress responses pathways. It associates with other cellular components to form complexes that guide substrate selectivity and ubiquitination. HECTD2’s regulatory role impacts cell cycle progression and apoptosis thereby influencing cell survival. Researchers have observed its interactions with proteins involved in the inflammation process suggesting a role in immune response modulation.
Pathways
HECTD2 acts within the NF-kB signaling pathway and the endoplasmic reticulum-associated degradation (ERAD) pathway. In the NF-kB pathway HECTD2 regulates the degradation of specific inhibitory proteins facilitating the activation of NF-kB a transcription factor important for immune response. It also interacts with other proteins like IκBα. HECTD2's involvement in the ERAD pathway supports its role in ensuring proper folding and degradation of proteins in the endoplasmic reticulum integrating with proteins such as BiP/GRP78.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
In vivo (Athens, Greece) 38:1094-1103 PubMed38688591
2024
Applications
Unspecified application
Species
Unspecified reactive species
The ISME journal 16:1205-1221 PubMed34972816
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 20: PubMed31756985
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com